As marijuana legalization gains momentum in the United States, researchers worry about keeping the public safe, particularly on the roads. Recent studies have identified new biomarkers that can be used to estimate a person’s recent cannabinoid intake. But, using those markers to judge cognitive and behavioral impairment is complex, say toxicologists.